Prof Dr. Chi-Tai Yeh | Innovative Leadership | Excellence in Research | 2803 Posted on 05/06/202407/06/2024 by ScienceFather Prof Dr. Chi-Tai Yeh | Innovative Leadership | Excellence in Research Prof Dr. Chi-Tai Yeh,Taipei Medical University-Shuang Ho Hospital, Professional Profile Orcid Education 🎓 Post-Doctoral Fellow | Jan 2006 – Jan 2010 National Institute of Cancer Research, Taiwan (R.O.C) National Health Research Institutes Ph.D. in Food Science and Biotechnology | Aug 2001 – Aug 2005 National Chung Hsing University, Taiwan (R.O.C) Current Positions 📈 Professor | Apr 2021 – Present Continuing Education Program of Food Biotechnology Applications, College of Science and Engineering, National Taitung University, Taiwan (R.O.C) Joint Appointment Research Fellow and Executive Secretary | Feb 2014 – Present Department of Research, Taipei Medical University – Shuang Ho Hospital, Taiwan (R.O.C) Assistant Professor | Apr 2010 – Present Graduate Institute of Clinical Medicine, Taipei Medical University, Taiwan (R.O.C) Professional Appointments and Experience 💼 Authored 91 articles in cancer and nutritional chemistry journals 📄 Contributed to 2 book chapters 📚 Secured 6 patents in cancer therapy compounds 🔬 Research Focus: Cancer cell biology Cancer stem cell studies Nutrigenomics Cancer prevention using dietary phytochemicals 🍎 Key Objectives: Disrupt tumor growth and survival pathways Enhance chemosensitivity and/or radiosensitivity Develop methods to counter tumor metastasis Test therapeutic interventions with tumor metastasis suppressor genes in preclinical trials Employ high-throughput proteomic analysis to discover new tumor metastasis markers and evaluate therapeutic approaches Notable Achievements 🏆 5292 Citations 📈 h-Index: 42 🎖️ Developed new methods to counter tumor metastasis and enhance treatment efficacy in cancer therapy Publication Top Noted: Paper Title: PAICS/DYRK3 Multienzyme Interactions as Coregulators of Purinosome Formation and Metabolism on Radioresistance in Oral Squamous Cell Carcinoma Paper Title: Tumor-Associated Macrophages Affect the Tumor Microenvironment and Radioresistance via the Upregulation of CXCL6/CXCR2 in Hepatocellular Carcinoma Paper Title: Furanocoumarin Notopterol: Inhibition of Hepatocellular Carcinogenesis through Suppression of Cancer Stemness Signaling and Induction of Oxidative Stress-Associated Cell Death Paper Title: Correction: Chen et al. Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis. Cancers 2021, 13, 3227 Paper Title: Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression